2011
DOI: 10.1016/j.ajem.2010.05.024
|View full text |Cite
|
Sign up to set email alerts
|

A case of rivastigmine toxicity caused by transdermal patch

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 7 publications
0
6
0
Order By: Relevance
“…Currently, there are disadvantages associated with current Alzheimer’s disease chemotherapeutics. For example, tacrine was observed to have serious side effects such as elevated liver transaminases and gastrointestinal problems [ 10 , 11 ]; donepezil has been reported to exhibit toxicity similar to beta-blocker overdose and colitis [ 12 ]; the toxicity of rivastigmine is thought to be similar to that of other carbamates and organophosphates with features of muscarinic and nicotinic stimulation [ 13 ]. Essential oils and their chemical constituents have been shown to have effects on the central nervous system, including in the treatment of Alzheimer’s disease and Parkinson’s disease [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there are disadvantages associated with current Alzheimer’s disease chemotherapeutics. For example, tacrine was observed to have serious side effects such as elevated liver transaminases and gastrointestinal problems [ 10 , 11 ]; donepezil has been reported to exhibit toxicity similar to beta-blocker overdose and colitis [ 12 ]; the toxicity of rivastigmine is thought to be similar to that of other carbamates and organophosphates with features of muscarinic and nicotinic stimulation [ 13 ]. Essential oils and their chemical constituents have been shown to have effects on the central nervous system, including in the treatment of Alzheimer’s disease and Parkinson’s disease [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Serum ChE should be periodically measured in patients with cholinesterase inhibitors to avoid lifethreatening adverse effects. [3] 150/80 106 87 M ND [21] 169/119 88 38 M 947 U/g hemoglobin (range, 2710-11510 U/g) [22] 180/90 79 59 M 6.0 μkat/L (range, 60-190 μkat/L) [23] 186/61 83 91 F 35 [24] 207/85 101 80 F ND [25] Vital signs and serum cholinesterase (ChE) upon initial presentation are summarized for patients A (distigmine) and B (rivastigmine) BP blood pressure, PR pulse rate, ND not determined *Reference article did not include the reference range…”
Section: Resultsmentioning
confidence: 99%
“…A nationwide database study showed that the iatrogenic cholinergic crisis is a rare but potentially life-threatening condition in Japan [1]. The clinical features resemble carbamate and organophosphate poisoning with symptoms that include both muscarinic (e.g., salivation, lacrimation, urination, defecation, miosis, bronchorrhea, and bradycardia) and nicotinic (e.g., muscle weakness, fasciculations, and paralysis) stimulation [2,3]. Here, we present 2 cases of cholinergic crisis caused by the reversible cholinesterase inhibitors; distigmine and rivastigmine focused on changes in blood pressure (BP) and pulse rate (PR).…”
Section: Introductionmentioning
confidence: 99%
“…There are several prior reports of toxicity from rivastigmine patches in adults but none in pediatric patients. 16,18 Theoretically, these patches could pose a risk similar to those described with transdermal fentanyl or clonidine. 19,20 However, only 3 cases were reported in our study, and none reported any symptoms.…”
Section: Discussionmentioning
confidence: 99%